Title |
Venture funding for science-based African health innovation
|
---|---|
Published in |
BMC Public Health, December 2010
|
DOI | 10.1186/1472-698x-10-s1-s12 |
Pubmed ID | |
Authors |
Hassan Masum, Justin Chakma, Ken Simiyu, Wesley Ronoh, Abdallah S Daar, Peter A Singer |
Abstract |
While venture funding has been applied to biotechnology and health in high-income countries, it is still nascent in these fields in developing countries, and particularly in Africa. Yet the need for implementing innovative solutions to health challenges is greatest in Africa, with its enormous burden of communicable disease. Issues such as risk, investment opportunities, return on investment requirements, and quantifying health impact are critical in assessing venture capital's potential for supporting health innovation. This paper uses lessons learned from five venture capital firms from Kenya, South Africa, China, India, and the US to suggest design principles for African health venture funds. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 22% |
South Africa | 4 | 22% |
Canada | 2 | 11% |
Uganda | 1 | 6% |
United Kingdom | 1 | 6% |
Unknown | 6 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 94% |
Scientists | 1 | 6% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Chile | 1 | 1% |
United States | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 71 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 16 | 22% |
Student > Master | 14 | 19% |
Student > Doctoral Student | 7 | 9% |
Other | 5 | 7% |
Student > Bachelor | 5 | 7% |
Other | 13 | 18% |
Unknown | 14 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Business, Management and Accounting | 15 | 20% |
Medicine and Dentistry | 10 | 14% |
Social Sciences | 5 | 7% |
Engineering | 5 | 7% |
Nursing and Health Professions | 4 | 5% |
Other | 16 | 22% |
Unknown | 19 | 26% |